Lumateperone safety study for children with schizophrenia, bipolar, or autism
Treatments studied
Part of Mental health clinical trials.
This trial tests a medication called lumateperone for children and teens with schizophrenia, bipolar disorder, or autism spectrum disorder. It aims to see if the medicine is safe and tolerable over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 5 and 17 years old, depending on their diagnosis: schizophrenia (13–17), bipolar I or II (10–17), or autism (5–17).
- They must have a confirmed diagnosis of schizophrenia, bipolar I or II, or autism spectrum disorder.
- They should be living at home (not in a hospital) and stay outpatient for the study.
- They cannot have a different major psychiatric disorder, but ADHD with stable medication is allowed, and mild to moderate intellectual disability is okay for children with autism.
- They must not have had recent suicidal thoughts or attempts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called lumateperone to see if it can improve apathy (lack of motivation) in people who have psychotic symptoms from schizophrenia or related disorders. It may help if you are already on a stable treatment but still struggle with apathy.
This trial tests whether adding lumateperone, an antipsychotic medication, to clozapine can improve metabolic health in people with schizophrenia. It aims to see if this combination helps with weight, blood sugar, and cholesterol levels.
This trial tests whether a safe, non-invasive brain stimulation treatment (called rTMS) is well-tolerated in children and teens with autism. rTMS uses magnetic pulses to gently stimulate parts of the brain, and this study wants to see if it can be given safely to young people with autism.
This Phase 4 study checks how safe and well-tolerated iloperidone is when used in a typical, open-label way for teenagers. It may help doctors better understand side effects and safety in teens with schizophrenia or bipolar I disorder.
This Phase 2 study tests zolpidem (a sleep medicine) to help children with autism sleep better. It will check sleep changes using sleep testing and to confirm zolpidem is safe for this age group.
This trial tests a new medication called LB-102 for people with acute (sudden worsening of) schizophrenia. It aims to see if the drug helps reduce symptoms like hallucinations or disorganized thinking.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.